Updates
-
News Cancer-sniffing Dogs May Help Train Robot Noses to Detect Tumors Early
-
News Prolaris Test Helps ID Higher-risk Patients Who May Safely Skip ADT
-
News Erleada-Zytiga Combo Delays Progression in mCRPC Patients, Phase 3 Trial Reports
-
News Erleada-ADT Combo Found to Prolong Survival, Delay Cancer Worsening
-
News ‘TRUE Love’ Contest Calls for Entries Honoring Caregivers
-
News Dosing Begins in Phase 1 Trial of FT-7051 for Advanced, Resistant Cancer
-
News Biological Clock Protein CRY-1 Eyed as Therapeutic Target
-
News EPI-7386 Combo Therapies Enter Trial for Certain mCRPC Patients
-
News Daily Coffee Drinking Lowers Prostate Cancer Risk, Study Suggests
-
News Active Surveillance Safe for Black Men With Low-risk Diagnosis, Study Finds
-
News Nubeqa Prescribing Information Updated With New Survival Data
-
News Orgovyx Now Available in US for Advanced Prostate Cancer
-
News Oral ARV-110 Shows Promise in Heavily Treated mCRPC Patients
-
News Long-term ADT Found to Raise Risk of Cardiovascular Death
-
News FDA Approves Orgovyx, Oral ADT for Advanced Prostate Cancer
-
News Teams Working in Advanced Cancer Win 2020 PCF Challenge Awards
-
News Study Describes New Way to Place CRISPR/Cas9 Into Cancer Cells
-
News Canada Approves Lynparza for Metastatic CRPC Patients With Certain Gene Mutations
-
News FDA Puts RV001 on Fast Track for Treating Prostate Cancer
-
News FDA Approves First PSMA-targeted PET Imaging Agent for Prostate Cancer
-
News FDA Approves FoundationOne Liquid CDx as Companion Test for Lynparza in mCRPC Patients
-
News, syndicated New $100M Program Aims to Improve Diversity in Clinical Trials
-
News PCF Helps Fund 2 Centers of Excellence to Treat Veterans With Prostate Cancer
-
News Puerto Rico to Test miR’s ‘Liquid Biopsy’ in Detecting Prostate Cancers
-
News AI-enabled Software To Detect Prostate Cancer Bone Metastases Clears FDA
-
News UK Study to Assess Causes of Greater Prostate Cancer Risk Among Black Men
-
News European Commission OKs Lynparza for Metastatic CRPC With BRCA Mutations
-
News Hold Lifted on Phase 1 Trial Testing P-PSMA-101 CAR T-cell Therapy in mCRPC
-
News CAR T-Cell Therapy, MB-105, Shows Promise in Metastatic CRPC Patient in Phase 1 Trial
-
News FDA Clears Ezra Prostate AI, a First for Cancer Imaging
-
News New Targeted Therapy Trial Opens, Part of PC-BETS Metastatic CRPC Study
-
News ADT Not Needed With Radiation in Favorable Intermediate-Risk PC
-
News Provenge Improves Survival in mCRPC Patients Over Xtandi, Zytiga, Real-world Study Finds
-
News Trial to Test Focal Laser Ablation Therapy for Localized Prostate Cancer
-
News New AI Algorithm Can Accurately Identify, Grade Prostate Cancer
-
News Veru Completes Enrollment for Second Part of Phase 1/2 VERU-111 Trial
-
News Lantheus Seeks FDA Approval of PyL Prostate Cancer Imaging Agent
-
News Relugolix Fails to Delay Castration Resistance in Advanced PC, Trial Shows
-
News Most nmCRPC Patients Can Safely Take Full Dose of Nubeqa, Trial Analysis Shows
-
News Phase 1 Trial of Oral Treatment for Metastatic CRPC Doses First Patient
-
News Lynparza’s Approval Favored in EU for mCRPC Patients with BRCA Mutations
-
News NCI Grant to Probe Link Between Prostate Cancer and Fatty Cells in Bone Marrow
-
News NIH Grants Dartmouth Team $2.5M to Develop Device for Detecting Cancer Cells
-
News IPCR Launches Exercise Video Series for Prostate Cancer Patients
-
News ‘Eat It to Beat It’ Challenge to Honor Prostate Cancer Awareness Month
-
News FDA Approves Blood Test That Can Identify Cancers Eligible for Targeted Therapies
-
News Tolmar Affirms Full Supply of Eligard for Palliative Treatment of Prostate Cancer
-
News Google AI System Outperforms General Pathologists in Grading Prostate Cancers, Study Finds
-
News Dosing Begins in Trial of PET Imaging Agent to Detect Prostate Cancer’s Return
-
News Cryotherapy May Ably Treat Intermediate-risk Prostate Cancer
-
News Collaboration Seeks to Reduce Prostate Cancer Disparities in African Americans
-
News New Guidelines for Care of Advanced Prostate Cancer Released
-
News New Risk Calculator May Help Men With High PSA Decide on Having Prostate Biopsy
-
News First AI-based Cancer Detection Application Slated for UK Rollout
-
News Laser Focal Therapy Effective, Causes Few Side Effects, 10-Year Trial Data Shows
-
News University of Colorado Launches PreView Medical for PC Diagnosis, Treatment
-
News Vaccine Shows Promise in Advanced Prostate Cancer, Proof-of-Concept Study Shows
-
News, syndicated FDA’s New ‘Project Patient Voice’ to Share Symptoms Data From Cancer Trials
-
News Ipatasertib Combo Fares Well in Early Results of IPATential150 Phase 3 Study
-
News Relugolix Granted FDA Priority Review as New Treatment Type
-
News Recommendation Against PSA Routine Screening May Have Contributed to Higher Rates of Advanced PC
-
News Veyonda Aids Radiation Therapy in Reaching Distant Lesions in Late-stage Cancer Trial
-
News Cancer DNA Levels in Blood Can Predict Treatment Responses
-
News Xtandi Plus ADT Bolsters Survival in High-risk Patients, Phase 3 Trial Finds
-
News U.K. Study to Examine Genetic Screening for Large Prostate Cancer Population
-
News NHS England Offers Xtandi, Zytiga to New PC Patients During COVID-19 Pandemic
-
News ADT May Protect Prostate Cancer Patients from COVID-19, Study Suggests
-
News Updated Guidelines Recommend Rubraca for Some Prostate Cancer Patients
-
News Rubraca Receives Conditional FDA Approval for metastatic CRPC Patients with BRCA Mutations
-
News FDA Approves Lynparza for mCRPC Patients with Mutations in DNA Repair Genes
-
News Erleada Add-on Significantly Extends Survival in Non-metastatic CRPC, SPARTAN Analysis Shows
-
News Yervoy Can Benefit Certain mCRPC Patients with Few Mutations in Tumors, Trial Finds
-
News, syndicated Surge in Telemedicine One ‘Good’ Outcome from COVID-19 Crisis, Doctors Say
-
News FDA Asked to Approve Relugolix to Treat Advanced Prostate Cancer
-
News Cancer Vaccine Plus Opdivo Showing Promise in Advanced Prostate Cancer Trial
-
News Gene Variant Seen to Promote Castration-resistant Disease in Whites
-
News Winners Named for Prostate Cancer Foundation’s TRUE Love Awareness Contest
-
News Guidelines for Radiation Therapy with COVID-19 Urge Less Treatment
-
News Combining Two Biopsy Methods Improves PC Diagnosis, Study Shows
-
News Urine Biomarkers Can Be Used to Develop Test for Prostate Cancer, Study Finds
-
News Proscia and UCSF Partnering to Deliver AI Apps to Improve Cancer Diagnosis
-
News Veru Advances Prostate Cancer Therapy VERU-111 to Phase 2 Portion of Trial
-
News Adoptive Cell Therapy Can Slow Prostate Cancer Growth, Study in Mice Reports
-
News Ciforadenant Has Promising Anti-tumor Activity in mCRPC, Early Data Show
-
News Prolaris Test Predicts Which PC Patients Benefit from Combo Therapy, Study Finds
-
News 3 New miR Scientific Urine Tests Diagnose, Classify Prostate Cancer, Data Shows
-
News Video: BioNews’ Social Media Campaign Highlights #WhatMakesMeRare
-
News Genetic Test Seen to Predict Patients Helped by ADT Use After Surgery
-
News Statins, Metformin May Extend Survival in High-risk Prostate Cancer, Large Study Suggests
-
News Decipher GRID ‘Signature’ Predicts Chemo Benefits in HSPC, Research Shows
-
News High Vegetable Diet Does Not Halt Prostate Cancer, Study Finds
-
News Cabometyx-Tecentriq Combo Leads to Lasting Response in Men with Advanced PC, Phase 1b Trial Data Shows
-
News Adding Provenge to Xtandi, Zytiga Reduces Risk of Death by 45% in mCRPC Patients, Data Shows
-
News Onvansertib’s Addition Aids Responses to Zytiga Even in Resistant Patients, New Trial Data Show
-
News eRapa Leads to Boost in Immune Cells in Low-Grade Prostate Cancer Patients, Phase 1b Data Suggest
-
News UPenn Researchers Awarded $500K Grant to Develop CAR T-cell Therapy for Advanced PC
-
News Xtandi Significantly Improves Overall Survival in Men with High-risk CRPC, Phase 3 Final Data Show
-
News Concerto, Pfizer Expand Data Partnership to Include Prostate, Other Cancers
-
-
-
Erleada-Zytiga Combo Delays Progression in mCRPC Patients, Phase 3 Trial Reports
Combining Erleada (apalutamide) and Zytiga (abiraterone acetate) to treat metastatic castration-resistant prostate cancer (mCRPC) significantly extends the time patients live without signs of disease worsening, compared ... Read more -
-
Subscribe to our mailing list
Get regular updates delivered to your email box.